文献速递心脑血管急症重症综合管理与镇静镇痛

疫苗诱导免疫性血栓性血小板减少症相关与非相关重型脑静脉窦血栓形成减压手术后的结局:多中心队列研究

Outcomes After Decompressive Surgery for Severe Cerebral Venous Sinus Thrombosis Associated or Not Associated with Vaccine-Induced Immune Thrombosis with Thrombocytopenia: A Multicenter Cohort Study.
PubMed 文献 · Neurocrit Care · 2023-07-27
一句话结论VITT相关CVST行减压手术者术前中线移位≥4 mm更常见(100% vs 68.8%,p=0.043)、3个月良好结局(mRS≤3)更多(p=0.043),作者认为应早期考虑减压手术。

这项多中心回顾性队列研究从12家三级中心收集行减压手术的VITT相关与非VITT相关CVST患者各16例,比较临床病程、围手术期与ICU管理及长期功能结局。两组入院时人口学、症状类型和影像学表现均衡,入院时和术前NIHSS严重程度相似;VITT相关CVST组术前中线移位≥4 mm者更多(100% vs 68.8%,p=0.043),倾向在入院后≤24小时内行减压手术(p=0.077),围手术期更常接受血小板输注、氨甲环酸和纤维蛋白原。术后管理相当、并发症分布均匀;VITT相关CVST组3个月良好结局(mRS≤3)者更多(p=0.043)。作者认为尽管个体病程预测仍有挑战,VITT相关CVST应早期考虑减压手术,因这些患者总体良好结局似乎可实现。

要点

  • 行减压手术的VITT相关CVST患者术前中线移位≥4 mm者占100%,非VITT组占68.8%(p=0.043)。
  • VITT相关CVST组3个月良好结局(mRS≤3)者更多,组间比较p=0.043。
  • VITT相关CVST组倾向在入院后≤24小时内行减压手术(p=0.077)。
  • VITT相关CVST组围手术期更常接受血小板输注、氨甲环酸和纤维蛋白原。
  • 两组术后管理相当,并发症分布均匀。

适用人群与场景

  • 12家三级中心收治的行减压手术的VITT相关CVST患者16例与非VITT相关CVST患者16例。
  • 两组入院时人口学、临床症状类型和影像学表现均衡,入院时及术前NIHSS严重程度相似。

处置流程与药物剂量

  • VITT相关CVST患者围手术期更常接受血小板输注、氨甲环酸和纤维蛋白原。
  • 两组术后管理相当,并发症分布均匀。

红旗征与不能漏的情况

  • VITT相关CVST患者术前中线移位≥4 mm者占100%,非VITT组占68.8%(p=0.043)。

研究设计与关键结果

  • 多中心回顾性队列研究,12家三级中心,VITT相关CVST与非VITT相关CVST行减压手术者各16例。
  • 术前中线移位≥4 mm:VITT相关CVST组100% vs 非VITT组68.8%,p=0.043。
  • VITT相关CVST组倾向在入院后≤24小时内行减压手术,p=0.077。
  • VITT相关CVST组围手术期更常接受血小板输注、氨甲环酸和纤维蛋白原。
  • 术后管理相当,并发症分布均匀。
  • 3个月良好结局(mRS≤3):VITT相关CVST组更多,p=0.043。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管个体病程预测仍有挑战,VITT相关CVST应早期考虑减压手术,因这些患者总体良好结局似乎可实现。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Clinical observations indicated that vaccine-induced immune thrombosis with thrombocytopenia (VITT)-associated cerebral venous sinus thrombosis (CVST) often has a space-occupying effect and thus necessitates decompressive surgery (DS). While comparing with non-VITT CVST, this study explored whether VITT-associated CVST exhibits a more fulminant clinical course, different perioperative and intensive care unit management, and worse long-term outcome.

METHODS: This multicenter, retrospective cohort study collected patient data from 12 tertiary centers to address priorly formulated hypotheses concerning the clinical course, the perioperative management with related complications, extracerebral complications, and the functional outcome (modified Rankin Scale) in patients with VITT-associated and non-VITT CVST, both with DS.

RESULTS: Both groups, each with 16 patients, were balanced regarding demographics, kind of clinical symptoms, and radiological findings at hospital admission. Severity of neurological symptoms, assessed with the National Institute of Health Stroke Scale, was similar between groups at admission and before surgery, whereas more patients with VITT-associated CVST showed a relevant midline shift (≥ 4 mm) before surgery (100% vs. 68.8%, p = 0.043). Patients with VITT-associated CVST tended to undergo DS early, i.e., ≤ 24 h after hospital admission (p = 0.077). Patients with VITT-associated CVST more frequently received platelet transfusion, tranexamic acid, and fibrinogen perioperatively. The postoperative management was comparable, and complications were evenly distributed. More patients with VITT-associated CVST achieved a favorable outcome (modified Rankin Scale ≤ 3) at 3 months (p = 0.043).

CONCLUSIONS: Although the prediction of individual courses remains challenging, DS should be considered early in VITT-associated CVST because an overall favorable outcome appears achievable in these patients.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Pelz JO, Kenda M, Alonso A, et al. Outcomes After Decompressive Surgery for Severe Cerebral Venous Sinus Thrombosis Associated or Not Associated with Vaccine-Induced Immune Thrombosis with Thrombocytopenia: A Multicenter Cohort Study. Neurocrit Care. 2023. PMID: 37498459. doi:10.1007/s12028-023-01782-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。